Printer Friendly

Browse Postmenopausal women topic

Care and treatment subtopic


1-158 out of 158 article(s)
Title Author Type Date Words
Switzerland : Novartis Kisqali data show superior overall survival compared to fulvestrant and consistent efficacy across advanced breast cancer patient subgroups in MONALEESA-3. Dec 17, 2019 442
Early postmenopausal risk management leads to 'optimum health' for women. Craven, Jeff Dec 1, 2019 1009
Key breast cancer summit highlights latest innovations. Nov 27, 2019 1033
Cancer Patients With Obesity Show Poorer Psychosocial Health; Among breast cancer and prostate cancer patients, scores for distress higher for obese than nonobese. Nov 26, 2019 277
Endocrine Therapy Lowers QOL for Breast Cancer Patients; Effects of chemotherapy found to be more transient in comparison. Nov 25, 2019 283
Physical Activity After Cancer Diagnosis Improves Survival; Findings seen among postmenopausal breast cancer patients regardless of activity level prediagnosis. Nov 13, 2019 342
Try testosterone for some women with sexual dysfunction. Kilgore, Christine Oct 1, 2019 1287
Task force: Data support testosterone therapy only for women with HSDD. Kilgore, Christine Oct 1, 2019 1232
CPH-I and HE4 Are More Favorable Than CA125 in Differentiating Borderline Ovarian Tumors from Epithelial Ovarian Cancer at Early Stages. Wang, Zhiheng; Tao, Xiang; Ying, Chunmei Oct 1, 2019 5542
Position Statement Clarifies Benefits of Testosterone Therapy for Women; Testosterone only recommended for postmenopausal women with hypoactive sexual desire dysfunction. Sep 5, 2019 256
International consensus on testosterone treatment for women. Sep 2, 2019 1345
Radius Health announces initiation of Phase 3 wearABLe study. Aug 5, 2019 297
Amgen (NASDAQ: AMGN) - Amgen and UCB Provide Regulatory Update on Status of EVENITY[TM] (romosozumab) in the EU -- 27/6/2019. Jul 4, 2019 430
Amgen (NASDAQ:AMGN) - Amgen and UCB Provide Regulatory Update on Status of EVENITY[TM] (romosozumab) in the EU -- 27/6/2019. Jul 4, 2019 429
Hepatoid Carcinoma of the Ovary: Clinical, Histopathologic, and Immunophenotypic Features. Acosta, Andres M.; Pins, Michael R. Jul 1, 2019 6042
United States : Amgen and UCB Provide Regulatory Update on Status of EVENITY (romosozumab) in the EU. Jul 1, 2019 418
New Guidelines for Treating Osteoporosis. Jun 1, 2019 126
Menopause UPDATE. Kaunitz, Andrew M.; McCullough, Deanna C. Jun 1, 2019 2614
Laser Therapy in the Treatment of Female Urinary Incontinence and Genitourinary Syndrome of Menopause: An Update. Franic, Damir; Fistonic, Ivan Jun 1, 2019 7649
Platelet/lymphocyte ratio is an independent predictor for osteoporosis. Eroglu, Semra; Karatas, Gulsah Report Apr 1, 2019 4872
Switzerland : Novartis data demonstrates consistent efficacy and tolerability of Kisqali combination therapy in HR+/HER2- advanced breast cancer in patients with difficult-to-treat visceral disease. Dec 10, 2018 424
Treatment Outcomes of Postmenopausal Osteoporosis in Patients with Stable Hypothyroidism: A 5-Year Follow-up Retrospective Study. Yilmaz, Volkan; Umay, Ebru; Gundogdu, Ibrahim; Tezel, Nihal Report Dec 1, 2018 4569
STUDY OF HORMONE RECEPTOR STATUS IN CARCINOMA BREAST. Somani, Kiran; Kansal, Abhishek; Singh, Raghvendra; Patel, Akhilesh; Datey, Sanjay Sep 17, 2018 2139
A Rare Cause of Acute Urinary Retention: Urethral Caruncle/Nadir Bir Akut Uriner Retansiyon Sebebi: Uretral Karunkul. Akdemir, Fatih Report Sep 1, 2018 1173
Urethral Squamous Cell Papilloma: A Rare Case Report and Review of the Literature/Uretranin Skuamoz Hucreli Papillomu: Nadir Bir Olgu Sunumu ve Literaturun Gozden Gecirilmesi. Celik, Serdar; Ozgur, Halil Hakan; Yorukoglu, Kutsal; Mungan, Mehmet Ugur Report Jun 1, 2018 1283
Understanding and Resolving Dyspareunia's Distress on Women and Clinicians. Kingsberg, Sheryl A. May 1, 2018 4218
Innovations in the Treatment of Dyspareunia. Portman, David J. May 1, 2018 4796
GTx announces early completion of patient enrollment in ASTRID trial. Apr 9, 2018 146
Are Postmenopausal Symptoms Disrupting Your Life? Lasers offer a non-hormone, drug-free treatment option. Apr 1, 2018 690
First Patient Dosed in Merrimack Phase 2 Clinical Study of MM-121 in Patients with Post-Menopausal Metastatic Breast Cancer. Clinical report Mar 1, 2018 257
Prognostic Signatures Compared for ER-Positive Breast Cancer; ROR, BCI, EPclin are significantly more prognostic for recurrence for women with node-negative disease. Feb 20, 2018 250
Safety Assessment of Neoadjuvant Pertuzumab Combined with Trastuzumab in Nonmetastatic HER2-Positive Breast Cancer in Postmenopausal Elderly Women of South Asia. Hussain, Nadia; Said, Amira S.A.; Khan, Zainab Report Jan 1, 2018 4618
Mending a Broken Heart: Treatment of Stress-Induced Heart Failure after Solid Organ Transplantation. Galvan, N. Thao; Kumm, Kayla; Kueht, Michael; Ha, Cindy P.; Yoeli, Dor; Cotton, Ronald T.; Rana, Abb Jan 1, 2018 6017
Does the Risk of Ovarian Malignancy Algorithm Provide Better Diagnostic Performance Than HE4 and CA125 in the Presurgical Differentiation of Adnexal Tumors in Polish Women? Abdalla, Nabil; Piorkowski, Robert; Bachanek, Michal; Stanirowski, Pawel; Cendrowski, Krzysztof; Saw Clinical report Jan 1, 2018 7536
Challenges of Treating Urinary Tract Infections in Post-Menopausal Women. Baker, Jan Jan 1, 2018 11033
Current scenario of menopause-related symptoms using menopause rating scale among middle-aged women of Western India: A cross-sectional study. Patel, Mansi; Shah, Venu; Kamani, Hardika; Sonaliya, Kantibhai Report Jan 1, 2018 2771
BONE HEALTH. Goldstein, Steven R. Dec 1, 2017 2376
AstraZeneca receives approval for Faslodex by EC. Jul 27, 2017 268
AstraZeneca receives approval for Faslodex by EC. Jul 27, 2017 264
United Kingdom : Faslodex receives EU approval as first-line therapy for advanced breast cancer. Jul 27, 2017 450
Why Are Some Women More Vulnerable To Depression? Jul 20, 2017 556
USPSTF discourages postmenopausal hormone therapy for prevention. Splete, Heidi Jun 1, 2017 404
What's the treatment? May 28, 2017 263
Bioidentical hormone replacement fares well in phase III trial. Oakes, Kari May 1, 2017 751
AMAG purchases US rights to Intrarosa (Prasterone) for treating post-menopausal VVA women. Apr 5, 2017 222
AMAG purchases US rights to Intrarosa (Prasterone) for treating post-menopausal VVA women. Apr 5, 2017 218
A Rare Case of Metastatic Choriocarcinoma of Lung Origin. Rali, Parth; Xie, Jianwu; Rali, Grishma; Rali, Mayur; Silverman, Jan; Malik, Khalid Case study Jan 1, 2017 1626
Traditional Chinese Medicine Bionic Tiger Bone Powder for the Treatment of AI-Associated Musculoskeletal Symptoms. Li, Yifan; Zhang, Zhenhua; Cui, Feifei; Liu, Jialing; Wang, Yitong; Jiang, Juling; Ma, Wenxin; Lu, W Report Jan 1, 2017 4718
Frequency of CYP2D6*10 genotypes in Pakistani breast cancer patients taking adjuvant tamoxifen. Dec 31, 2016 2837
Effect of Half-dose and Standard-dose Conjugated Equine Estrogens Combined with Natural Progesterone or Dydrogesterone on Components of Metabolic Syndrome in Healthy Postmenopausal Women: A Randomized Controlled Trial. Xue, Wei; Deng, Yan; Wang, Yan-Fang; Sun, Ai-Jun Dec 5, 2016 4414
Effects of exercise on low density lipoprotein receptor related protein 5 gene expression in patients with postmenopausal osteoporosis. Kilic, Gamze; Erden, Didem Dayangac; Erol, Ozlem; Kilic, Erkan; Kara, Murat; Yurter, Hayat Erdem; Ak Dec 1, 2016 4023
United States : PALOMA-2 Phase 3 Study Published in The New England Journal Of Medicine Demonstrates Clinical Benefit Of Pfizers IBRANCE (palbociclib) In First-Line ER+, HER2- Metastatic Breast Cancer. Nov 17, 2016 363
Switzerland : Novartis breakthrough therapy LEE011 plus letrozole demonstrates superior progression-free survival as first-line treatment for HR+/HER2- advanced breast cancer compared to a standard of care. Oct 10, 2016 916
Switzerland : Novartis CDK4/6 inhibitor LEE011 (ribociclib) receives FDA Breakthrough Therapy designation as first-line treatment for HR+/HER2- advanced breast cancer. Aug 5, 2016 441
Menopause: recent trial results on the cardiovascular safety of hormone therapy in early menopausal women are reassuring, while survey data reveal millions of women are using unvetted and unregulated custom compounded hormone therapy for menopausal symptoms. Kaunitz, Andrew M. Jul 1, 2016 3275
Hormone replacement therapy: consider pros and cons carefully: for younger postmenopausal women in good overall health, the benefits may outweigh the risks of HRT. Jul 1, 2016 717
Belgium : UCB commitment to addressing real world patient needs on display at the Annual European Congress of Rheumatology (EULAR 2016). Jun 8, 2016 584
AstraZeneca to offer treatment options to postmenopausal women with HR+ locally-advanced or metastatic breast cancer upon successful Phase III FALCON trial. May 30, 2016 300
AstraZeneca to offer treatment options to postmenopausal women with HR+ locally-advanced or metastatic breast cancer upon successful Phase III FALCON trial. May 30, 2016 296
Switzerland : MONALEESA-2 trial of Novartis' LEE011 (ribociclib) stopped due to positive efficacy results at interim analysis in HR+/HER2- advanced breast cancer. May 19, 2016 267
Prevalence of dry eye in post-menopausal women. Pujari, M.R.; Salagar, Kavita; Bagare, Sheetal N. Clinical report Sep 17, 2015 2042
Ultrasonographic Observation of the Breast in Early Postmenopausal Women during Therapy with Cimicifuga Foetida Extract and Sequential Therapy with Estrogen and Progestin. Gaowa, Sharen; Sun, Ai-Jun; Jiang, Ying; He, Fa-Wei; Zheng, Ting-Ping; Wang, Ya-Ping Report Aug 1, 2015 3937
What does vitamin D have to do with cancer? Report Jul 1, 2015 466
Higher folate levels associated with improved survival in breast cancer patients. Brief article May 1, 2015 214
Primary fallopian tube carcinoma: case report. Onimi, Syamala; Godla, Usha Rani Mar 16, 2015 988
Importance of further recognition of atherosclerotic patients candidate for CABG: predisposing factors for postoperative stroke. Sheikhi, Mohammad Ali; Ebadi, Ahmad; Rahmani, Hossein Report Mar 1, 2015 3510
Role of hysteroscopy in gynaecological problems. Kamra, Jyotsna Harlalka; Kaur, Mandeep Clinical report Feb 9, 2015 3445
SERMs move beyond osteoporosis, breast cancer. Boschert, Sherry Dec 1, 2014 188
Pfizer's NDA for Palbociclib accepted for US FDA's priority review for first-line therapy in combination with letrozole in postmenopausal women with breast cancer. Oct 14, 2014 223
Pfizer's NDA for Palbociclib accepted for US FDA's priority review for first-line therapy in combination with letrozole in postmenopausal women with breast cancer. Oct 14, 2014 219
Simple endometrial hyperplasia--post Tamoxifen therapy in a patient of carcinoma breast. Valluvan, M.; Divvya, B.; Viswanathan, P.; Tippo, Rehana; Baskaran, R. Oct 6, 2014 702
Hormone therapy for menopausal vasomotor symptoms: given our available (better) options for treating hot flashes, can we reduce our use of medroxyprogesterone acetate? Barbieri, Robert L. Jul 1, 2014 2522
ASCO: extend adjuvant endocrine therapy to 10 years. Moon, Mary Ann Jun 1, 2014 485
Letrozole-induced very early systemic sclerosis in a patient with breast cancer: a case report. Pokhai, Gabriel; Buzzola, Rino; Abrudescu, Adriana Jun 1, 2014 1611
A study of triple assessment of breast cancer patients in a tertiary care hospital of Central India. Valecha, Jyoti; Gupta, Vivek; Mishra, Jharna; Chanchlani, Roshan Report May 12, 2014 2428
Breast cancer patients should exercise to ease drug-related joint pain. Dec 13, 2013 227
New studies aim to improve women's sex lives after menopause. Medical condition overview Dec 5, 2013 321
Your postmenopausal patient reports a history of migraine: would a trial of hormone therapy increase her risk of stroke? Simon, James A. Oct 1, 2013 2204
Switch to denosumab improved bone density. Boschert, Sherry Sep 15, 2013 691
The relationship between osteoarthritis and osteoporosis in patients with primary generalized osteoarthritis / Primer Jeneralize Osteoartritli Hastalarda Osteoartrit ve Osteoporoz Arasindaki Iliski. Zholdoshova, Aigul; Yalcin, Peyman Sep 1, 2013 6838
Dr. Tim Bilash Announces New Findings Refuting Previous Studies on Hormone Replacement Therapy, Offers Free Consultations. Jul 26, 2013 682
Clinical guidelines for family physicians: breast cancer prevention. Skolnik, Neil; Madsen, Megan May 15, 2013 752
Prevention and treatment of osteoporosis. Skolnik, Neil; Charles, Josya-Gony May 1, 2013 952
Randomized, double-blind placebo-controlled trial with Bryophyllum pinnatum versus placebo for the treatment of overactive bladder in postmenopausal women. Betschart, Cornelia; von Mandachb, Ursula; Seifertc, Burkhardt; Scheiner, David; Perucchini, Daniele Clinical report Feb 15, 2013 7765
Use HT for symptoms, not disease prevention. Smith, Jennie Nov 15, 2012 564
Japan : Eli Lilly Japan and Chugai to Terminate Co-Marketing Agreement of EVISTAA tablet 60mg, a Treatment for Osteoporosis in Postmenopausal Women. Nov 5, 2012 136
Lack of sleep may trigger aggressive breast cancers. Aug 28, 2012 252
The comparison of the effect of risedronate and strontium ranelate on bone mineral density in postmenopausal women/Postmenopozal kadinlarda risedronat ve stronsiyum ranelat'in kemik mineral yogunlugu uzerine etkisinin karsilastirilmasi. Yilmaz, Figen; Dogu, Beril; Sirzai, Hulya; Kuran, Banu Report Aug 1, 2012 4117
Novartisa[euro](tm) Afinitor approved by US FDA in advanced breast cancer. Jul 23, 2012 271
Women, estrogen, cognition, and Alzheimer's disease. Hathaway, Ann Clinical report Jun 1, 2012 5904
Estrogen-only HT increases breast cancer risk. Mahoney, Diana May 1, 2012 577
Estrogen-only HT increases breast cancer risk. Mahoney, Diana Apr 15, 2012 565
Estrogen-only HT may up breast cancer risk. Mahoney, Diana Apr 15, 2012 462
Side effects deter many breast cancer patients from treatment. Mar 1, 2012 132
Comparison of effects of two different hormone therapies on mood in symptomatic postmenopausal women/Semptomatik postmenopozal kadinlarda iki farkli hormon terapisinin ruhsal durum uzerine etkilerinin karsilastirilmasi. Karsidag, Cagatay; Karsidag, Ayse Yasemin Karageyim; Buyukbayrak, Esra Esim; Kars, Bulent; Pirimoglu Report Mar 1, 2012 3325
Osteoporosis: therapeutic interventions. Hudson, Tori Report Feb 1, 2012 8026
Manage hot flashes and other symptoms that continue past menopause: for severe symptoms, medications may be the only way to get relief. Feb 1, 2012 480
BioSante's Phase III LibiGel trials do not meet primary, secondary endpoints for treatment of HSDD in postmenopausal women. Dec 15, 2011 512
Flaxseed does not ease hot flashes during menopause or in breast cancer patients. Clinical report Sep 8, 2011 200
Effects of tibolone on bone mass in postmenopausal women: postmenopozal kadinlarda tibolonun kemik kutlesi uzerindeki etkisi. Krejovic, Snezana Maric; Zivanovic, Aleksandar; Hasani, Bajram; Ille, Tatjana; Glisic, Andrea Report Sep 1, 2011 3572
Flaxseed does not ease hot flashes during menopause or in breast cancer patients. Clinical report Jun 6, 2011 182
Malignant mixed mullerian tumor in two patients receiving tamoxifen therapy. Koukouliata, A. Report Jun 1, 2011 1725
12-O-Tetradecanoyl phorbol-13-acetate (TPA)-induced growth arrest is increased by silibinin by the down-regulation of cyclin Bl and cdc2 and the up-regulation of p21 expression in MDA-MB231 human breast cancer cells. Kim, Sangmin; Lee, Hye Sook; Lee, Se-Kyung; Kim, Sung Hoon; Hur, Sung Mo; Kim, Jee Soo; Kim, Jung-Ha Report Dec 1, 2010 4187
WHI: HT raises risk of invasive breast cancers. Moon, Mary Ann Nov 1, 2010 761
Calcium supplementation linked with decreased trunk fat gain in postmenopausal women. Dye, D. Brief article Nov 1, 2010 226
Try aromatase inhibitor for subset of breast Ca. Moon, Mary Ann Oct 1, 2010 900
Role of vitamin K2 in the treatment of postmenopausal osteoporosis. Report Sep 1, 2010 349
Effect of low dose vitamin K2 (MK-4) supplementation on bio-indices in postmenopausal Japanese women. Report Sep 1, 2010 255
Response of serum carboxylated and undercarboxylated osteocalcin to alendronate monotherapy and combined therapy with vitamin K2 in postmenopausal women. Report Sep 1, 2010 226
Vitamin K1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of age. Report Sep 1, 2010 261
Relationship between thyroid autoimmunity and depression, quality of life, and disease symptoms in patients with fibromyalgia and rheumatoid arthritis / Fibromyalji ve romatoid artritli hastalarda tiroid otoimmunitesinin, depresyon, yasam kalitesi ve hastalik semptomlan ile iliskisi. Baskan, Bedriye Mermerci; Sivas, Filiz; Aktekin, Lale Akbulut; Yurdakul, Fatma Gul; Cinar, Nilay Kil Report Sep 1, 2010 4290
The effects of bisphosphonates used continually or intermittently on fractures, bone mineral density and biochemical parameters in osteoporotic patients/Osteoporozlu hastalarda bifosfonatlarin devamli veya aralikli kullaniminin kirik, kemik yogunlugu ve biyokimyasal parametrelere etkisi. Cevikol, Alev; Umay, Ebru; Karaahmet, Ozgur Zeliha; Avluk, Ozlem Celik; Cakci, Aytul Report Apr 1, 2010 5109
Bisphosphonates may reduce breast cancer risk. Bates, Betsy Jan 1, 2010 797
Chemo plus tamoxifen beneficial for some breast cancer patients. Dec 11, 2009 538
An overview of menopausal oestrogen-progestin hormone therapy and breast cancer risk. Brief article Oct 1, 2009 188
Hormone use for menopausal symptoms and risk of breast cancer. A Danish cohort study. Brief article Oct 1, 2009 227
Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Brief article Oct 1, 2009 248
Intravaginal oestrogen and progestin administration: advantages and disadvantages. Clinical report Oct 1, 2009 168
Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause. Clinical report Oct 1, 2009 217
Resistance to hormone therapy in breast cancer. Hiscox, Stephen; Nicholson, Robert I. Report Sep 1, 2009 4410
Low bone mass: assessing absolute fracture risk and the need to treat younger postmenopausal women. Honig, Stephen Jul 1, 2009 3228
Pueraria mirifica and dyslipidemia. Finney-Brown, Tessa Report Jun 22, 2009 378
The clinical importance of patient adherence to therapy. Fallowfield, Lesley Report Jun 1, 2009 2006
AclastaA Approved in Jordan as the first once-yearly treatment for women with postmenopausal osteoporosis. Feb 2, 2009 522
Persistent low concentration of human chorionic gonadotropin in a nonpregnant woman. McCudden, Christopher R.; Willis, Monte S.; Grenache, David G. Jan 1, 2008 3009
Bazedoxifene helps reduce vertebral fracture risk after menopause. Muirhead, Greg Dec 1, 2007 573
Watch for poor bone health after breast cancer. Palkhivala, Alison Oct 15, 2007 604
The benefits and risks of hormone replacement therapy: hormone replacement therapy effectively treats postmenopausal symptoms, but has been linked to conditions like cancer and stroke. Hung, William Oct 1, 2007 653
Menopause, decency thwarted. Bell, John R. Brief article Mar 1, 2007 127
Low vitamin D tied to bone loss in breast cancer. MacNeil, Jane Salodof Aug 1, 2006 508
Results of a clinical trial. Brief article Feb 1, 2006 85
NAMS statement supports role for testosterone Tx. Schneider, Mary Ellen Dec 1, 2005 727
Serum tartrate-resistant acid phosphatase 5b or amino-terminal propeptide of type I procollagen for monitoring bisphosphonate therapy in postmenopausal osteoporosis? Valimaki, Matti J.; Tahtela, Riitta Dec 1, 2005 2330
Soy reduced vasomotor symptoms. Bates, Betsy Sep 15, 2005 493
Act locally and use behavioral approach for vaginal dryness. Finn, Robert Sep 15, 2005 381
Lasofoxifene: first SERM to reduce dyspareunia. Johnson, Kate Sep 1, 2005 565
Vitamin D inadequacy knows no boundaries. Jancin, Bruce Aug 15, 2005 782
Guideline: use aromatase inhibitor as adjuvant Tx. Mahoney, Diana Jun 15, 2005 1063
Zoledronic acid sustains bone in breast ca patients. Jancin, Bruce Feb 15, 2005 672
Hormone therapy in postmenopausal women. Golden, William E.; Hopkins, Robert H. Feb 1, 2005 819
Can transvaginal ultrasound detect endometrial disease among asymptomatic postmenopausal patients? Langlois, John P.; Turner, Linda F.; Aitken, Paul V., Jr. Dec 1, 2004 840
Triglycerides do not alter raloxifene's lipid effects. Jancin, Bruce Sep 1, 2004 372
Source and perceived quality of information are linked to users' odds of discontinuing hormone therapy. London, S. Mar 1, 2004 1259
Teriparatide cuts spinal fracture risk at all ages. (Postmenopausal Women). MacReady, Norra Brief Article Mar 1, 2003 431
Which postmenopausal women should be offered combined HRT? (Clinical Inquiries). Oliver, M. Norman; Sheufelt, Janice; Deshpande, Prajakta; Grandage, Karen K.; St. Anna, Leilani Feb 1, 2003 928
Cohosh hot stuff. (Body Wise). O'Grady, Kathleen Brief Article Jan 1, 2003 200
Hormone therapy: a prescription for replacement. Mitchell, Penni Jan 1, 2003 1519
Anastrozole bests tamoxifen in early breast cancer trial: A 17% drop in risk of disease recurrence was seen in postmenopausal patients. (ATAC Study of 9,366 Women). Jancin, Bruce Product/Service Evaluation Jan 15, 2002 682
Should postmenopausal women who are taking HRT continue for life? Jul 1, 2000 1012
HRT Raises Thromboembolism Rates in High-Risk Patients. CHENG, GUANG-SHING Feb 1, 2000 406
Estrogen Shouldn't Replace Exercise. GOLDMAN, ERIK L. Dec 1, 1999 852
Use of bone alkaline phosphatase to monitor alendronate therapy in individual postmenopausal osteoporotic women. Kress, Barry C.; Mizrahi, Isaac A.; Armour, Karen W.; Marcus, Robert; Emkey, Ronald D.; Santora, Art Jul 1, 1999 6229
Delivering estrogen after menopause. Brief Article Feb 1, 1998 303
Is routine use of estrogen indicated in postmenopausal women? An affirmative view. Mishell, Daniel R., Jr. Oct 1, 1989 3135
Estrogen in postmenopausal women: an opposing view. Notelovitz, Morris Oct 1, 1989 4089

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters